triGUT™
– The worlds most well documented probiotic complex

The complex is combination of three specific and world famous strains which, when administered in adequate volume offers superior clinical effects

Lactiplantibacillus plantarum ​
DSM 9843 ​
Lacticaseibacillus rhamnosus ​
GG ATCC 53103 ​
Bifidobacterium animalis spp lactis DSM 15954 ​

When choosing a probiotic solution for your consumer brand you do not want to make compromises.​ Digestive health matters the most to consumers (70% according to Lumina / Euromonitor).​ A consumer needs to experience “the difference” in a health area that is important to them, and triGUT™ delivers​.

triGUT™ was launched in Sweden 2022 with a clear value proposition covering the family’s full digestive needs in one product – Infants, children and adults – male and female.

Clinical Evidence

Taken together, the probiotic strains included in triGUT™, have been documented in more than 1200 published scientific studies of which more than 350 are clinical trials. triGUT™ brings several important health benefits in digestive health. It is estimated that 70% of consumers search for probiotics to help them with their gut health. triGUT™ is the worlds most documented probiotic complex and with extensive digestive health clinical documentation in the most important areas – examples:​

Abdominal pain and bloating

52% reduction of abdominal pain and 78% estimated treatment effectiveness in IBS patients (double blind placebo-controlled trial with 214 participants, p<0.05). >50% reduction of bloating in 44% of IBS patients (double blind placebo-controlled trial with 60 participants, p<0.05) ​

​Decreased infant cholic symptoms (Randomized controlled trial with 80 participants, p<0.05) ​

Diarrhea 

54% reduction of children with gastroenteritis experiencing diarrhea episodes compared with placebo (double blind, placebo controlled randomized trial with 124 children, p>0.05)

Constipation

Weekly changes from baseline in defecation frequency (intention-to-treat population). Defecation frequency recorded in subject diaries and reported as days per week with significantly different from placebo group at weeks 2, 3 and 4 (**P<0.01). CFU, colony-forming units 1 billion CFU, n 343, Placebo n 453.

With triGUT™, consumers do not need to search​
for different solutions but can rely on one optimal supplement for all of their gut health needs.